Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2016 - Issue 6
Submit an article Journal homepage
3,613
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies

Jadwiga A. WedzichaAirways Disease Section, National Heart and Lung Institute, Imperial College London, London, UKCorrespondence[email protected]
,
Alvar AgustiInstitut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, Barcelona, Spain
,
Gavin DonaldsonAirways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK
,
Ferran ChuecosAstraZeneca R&D Centre, Barcelona, Spain
,
Rosa LamarcaAstraZeneca R&D Centre, Barcelona, Spain
&
Esther Garcia GilAstraZeneca R&D Centre, Barcelona, Spain
Pages 669-676 | Received 02 Dec 2015, Accepted 18 Mar 2016, Published online: 09 May 2016

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Konstantinos Kostikas, Theodoros I Vassilakopoulos, Nikos Tzanakis, Athanasios K Konstantinidis, Epameinondas N Kosmas, Spyros Papiris, Paschalis Steiropoulos, Effrosyni D Manali, Stylianos A Michaelides & Grigorios Daskos. (2020) A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 515-526.
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Wouter H van Geffen & Huib AM Kerstjens. (2018) Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1269-1277.
Read now

Articles from other publishers (3)

James F. Donohue, Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann & Glenn D. Crater. (2020) Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis. BMC Pulmonary Medicine 20:1.
Crossref
Robert A. Wise, Kenneth R. Chapman, Benjamin M. Scirica, Deepak L. Bhatt, Sami Z. Daoud, Sofia Zetterstrand, Colin Reisner & Esther Garcia Gil. (2019) Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease. JAMA 321:17, pages 1693.
Crossref
A. A. Vizel & I. Yu. Vizel. (2018) 12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review. Medical Council:15, pages 116-122.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.